Address: 1st Floor Grapevine House, Steenberg Office Park, Silverwood Close,
Westlake, Cape Town, 7945,South Africa
Tel: (27) 21 707 7000
Web: http://www.pharmadynamics.co.za/
Pharma Dynamics: a trusted name in healthcare
Through strategic alliances with international partners, Pharma Dynamics pursues a vision to count itself among the names most trusted by South African healthcare professionals and consumers.
Just seven years since its launch, Pharma Dynamics has consistently been one of the fastest growing pharmaceutical companies in the country. Pharma Dynamics’ founder and managing director, Paul Anley, ascribes this achievement to an unyielding focus on delivering safe, effective, yet affordable medication to more South Africans.
‘This vision becomes reality through strategic partnerships, a passion for customer service, stringent quality control, and the passion of an adaptable, responsive team of people,’ says Anley.
Company Background
Pharma Dynamics is a privately owned pharmaceutical company, founded in January 2001 by Managing Director, Paul Anley B.Pharm MBA. Based in Cape Town, South Africa, Pharma Dynamics has marketing alliances, distribution agreements and contract manufacturing arrangements with several multinational companies. The company has experienced significant growth, driven by a passion to provide quality, affordable medication to more South Africans.
Focused investment in human resources, product procurement and marketing has reaped rewards. Pharma Dynamics is currently ranked within the top 10 generics companies in South Africa with a growth rate (34% MAT) in excess of a rapidly evolving generics market.
Our Mission
Pharma Dynamics is committed to become a world-class marketer and distributor of healthcare products in Southern Africa.
Generic Product Range
Antibiotics
Cardiovascular
Gastrointestinal
Neuropsychiatry
NSAIDs/ Analgesics
The Natural Shoppe
culturelle
fibrelle
nazo
phytocor
phytopause
The CEO of Pharma Dynamics explains why the company was the perfect match for Lupin, as the fastest growing, and largest independently owned acquirable pharmaceutical business in South Africa, why…
In 2005, when Focus Reports interviewed you, you were more towards the start up phase of Pharma Dynamics; and you have significantly grown in the market since then. What new…
Writing in the February 2024 edition of the DIA Global Forum magazine, Verena Pfaffinger and Ilona Baraniak-Lang of PharmaLex examine how the drug shortages seen in the global south during…
Tremendous strides have been made in both treatment and prevention of AIDS and it is no longer among the 10 leading causes of death globally, however an estimated 39 million…
Dr Benji Pretorius, the founder of Erada Technology Alliance and a malaria survivor himself, shares his insights into why the development of a truly effective malaria vaccine will only succeed…
Writing in the July 2023 edition of DIA’s Global Forum magazine, Nevena Miletic of Roche and the IFPMA’s Africa Regulatory Network and Ian Hudson from the Bill and Melinda Gates…
The third and final piece in Lenias Hwenda of Medicines for Africa’s series looking back at the challenges and successes of HIV/AIDS treatments over the past 40 years and potential…
The second in a three-part series looking back at the challenges and successes of HIV/AIDS treatments over the past 40 years and potential medical breakthroughs to come (read part one…
In the first of a series looking back at the challenges and successes of HIV/AIDS treatments over the past 40 years and potential medical breakthroughs to come, Lenias Hwenda of…
During the COVID-19 pandemic discussions around increasing access to medicines for low and middle-income countries (LMICs) were often centred on compulsory licensing. As a result, pharma companies were up in…
As part of a special focus on drug development and clinical research in Africa in February 2023’s DIA Global Forum magazine, Lisa Ursella Collins of Innomas Clinical Research, Leslie Sam…
Roughly half of Africa’s 1.1 billion people lack regular access to even the most essential medicines and most of Sub-Saharan Africa depends on imports which make up as much as…
Speaking exclusively to PharmaBoardroom, Medicines for Africa’s Lenias Hwenda gives a comprehensive overview of the African Medicines Agency, why such a regulatory body was needed, how it differs from the…
Lenias Hwenda of Medicines for Africa examines the true impact of access to medicine initiatives in Africa, noting that many of the measures takes are often cosmetic and leave a…
See our Cookie Privacy Policy Here
